Drug Maker Assessments Eyed to Subsidize Patient Costs
7/14/21 12:56 PM
House and Senate talks on legislation tackling pharmaceutical costs broke down last session, and a Senate leader has rolled onto the 2021 negotiating table a revised plan under which drug manufacturers would be forced to pay into a new state fund to assist Massachusetts residents with the costs of prescription drugs for several chronic health conditions.
Get the rest of the story!
Click here to start your free, no‑obligation, 21-day trial.
Latest COVID-19 Figures in Mass.
|New Confirmed Cases||153248|
|Total Confirmed Cases||766,883|
|House Surplus/ARPA Bill||Summary Bill Text|
|Monday||Opioid Bills Hearing Full Schedule|
|BCBSMA||Impact of ARPA on the MA Health Care System|
FREE for SHNS subscribers!